CD274 and neoplasm: Moreover, we found that GSK591 treatment not only inhibited tumor cell survival but also induced tumor cell expression of type 1 IFN response and CD274 genes, which activated the PD1/PD-L1 axis and eliminated T cell antitumor activity.